Physician

James Dimuzio, DO

According to 2025 Medicare claims, James Dimuzio, DO (NPI: 1306822424) practices otolaryngology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is COASTAL CAROLINA ENT DO PA (NPI: 1689757007; TIN: 562151484) and primary practice location at 28472-3714. Dimuzio is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dimuzio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,690 traditional Medicare patients, billed 15,968 HCPCS/CPT codes, and received $449,715 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 938 prescription claims across 384 beneficiaries totaling $80,972 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 28 claims. Open Payments data shows 15 records totaling $562. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $176,862 to $449,715. Similarly, Part D prescription costs have moved sharply higher in recent years, from $30,845 to $80,972. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,257 to $3,991.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	644	2,521	$176,862
2016	594	3,765	$220,785
2017	617	3,419	$241,632
2018	568	3,258	$243,796
2019	755	10,494	$271,133
2020	722	16,061	$265,656
2021	741	15,866	$295,470
2022	772	15,018	$317,843
2023	712	14,142	$293,917
2024	1,690	15,968	$449,715

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	618	$30,845
2016	302	701	$30,338
2017	335	773	$30,854
2018	348	821	$31,477
2019	393	936	$33,355
2020	378	927	$36,120
2021	464	1,097	$44,605
2022	473	1,086	$46,732
2023	422	1,009	$121,896
2024	384	938	$80,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$1,299
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	21	$817
2022	N/R	12	$330
2023	N/R	49	$2,319
2024	N/R	28	$1,388

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	283	360	$138
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	154	154	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	512	662	$99
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	538	538	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	704	1,010	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	17	476	$62,253
Cefdinir	Cefdinir	101	1,542	$2,540
Epinephrine	Epinephrine	12	158	$2,287
Fluticasone Propionate	Fluticasone Propionate	117	6,774	$2,158
Prednisone	Prednisone	149	1,054	$1,293

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	N/R	13	$1,220
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	15	$169

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$562	Integra LifeSciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Dimuzio, DO?

Tedicare shows public-source Medicare data for James Dimuzio, DO (NPI 1306822424), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Dimuzio, DO have ACO affiliation data?

James Dimuzio, DO is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James Dimuzio, DO?

James Dimuzio, DO is linked to COASTAL CAROLINA ENT DO PA (billing NPI 1689757007) in the available physician profile data.

Does James Dimuzio, DO have Open Payments data?

James Dimuzio, DO has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.